COMPLIANCE | INTEGRITY | SERVICE + SECURITY
WELCOME TO JOBCO
JOBCO Trade Services Inc is your trusted US Customs broker in Laredo. JOBCO helps clients deal with the ever changing and complex Customs import and export procedures and requirements. Our relationship with our clients is a partnership. We bring our experience, best practices and tools to meet our clients’ unique requirements.
JOBCO uses the latest state of the art capabilities to properly manage the clearance and handling of your shipments with Customs and other government agencies.
We have offices in Nuevo Laredo, Piedras Negras, Monterrey, Toluca and San Luis Potosi Mexico which allow us to offer Mexico import and export clearance as an integrated part of our service assuring control of pricing, security and service on both sides of the border.
JOBCO offers state of the art safe and secure warehouse and distribution services. Our facility is fully insured and secured with electronic video surveillance, alarms, perimeter fencing and controlled access.
Juan O. Bautista Customs Broker/JOBCO Trade Services Inc is a proud CTPAT Certified-validated company. Along with our certification, U.S. Customs and Border Protection, within the Department of Homeland Security, provide many benefits, allowing a secure and efficient flow of international cargo with reduced inspections.
- FDA Approves New Bladder Cancer Drug - Medscapeon April 23, 2024 at 3:11 pm
Medscape Medical News > FDA Approvals >. FDA Approves New Bladder Cancer Drug. Sharon Worcester, MA. April 23, 2024. 0. Receive email when new ...
- FDA Issues CRL to Abeona for Potential RDEB Cell Therapy - HCPLiveon April 23, 2024 at 3:03 pm
https://ir.aslanpharma.com/news-releases/news-release-details/aslan-pharmaceuticals-announces-positive-interim-results-phase-2. Stewart J. Dupixent ( ...
- FDA approves ImmunityBio's bladder cancer therapy combo - Endpoints Newson April 23, 2024 at 3:01 pm
Katherine Lewin. News Reporter. ImmunityBio scored an FDA approval for its once-rejected drug combo for bladder cancer, the biotech announced Monday ...
- FDA Approves Pillar Biosciences Pan-Cancer NGS Test for Solid Tumor Profilingon April 23, 2024 at 2:49 pm
Molecular Diagnostics · Regulatory News & FDA Approvals · Companion Diagnostics · Pillar Biosciences · personalized medicine · Sequencing. We ...
- Patients' Voices Largely Absent From FDA Reviews of New Cancer Drugs Patient Reported ...on April 23, 2024 at 2:34 pm
Thanks for visiting Renal & Urology News. We hope you're enjoying the latest clinical news, full-length features, case studies, and more. You've ...
- Avocado oil recalled due to packaging issue: FDA - WGN-TVon April 23, 2024 at 2:31 pm
WGN News Daily Update. SIGN UP NOW. Top Stories · The Latest | Tent compound rises in southern Gaza … This satellite image from Planet Labs PBC shows ...
- The FDA accelerated approval pathway works — but it isn't flawless - STAT Newson April 23, 2024 at 2:30 pm
In-depth survival data question a new study suggesting that accelerated approval drugs often do not improve clinical outcomes.